GlassScriptPhysician profile
Justin Peng
NPI 1538328141
$2,421.98
in general payments reported to CMS, 2019-2025
21 companies · $18.64 in 2025
The $18.64 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $210 · 2022: $326 · 2023: $1,036 · 2024: $36.25 · 2025: $18.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $720 · Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $720.27 |
| Food and Beverage | $370.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $953.03 | 2023-2025 | Iovera, Zilretta |
| Amgen INC. | $377.06 | 2019-2023 | Evenity, Prolia |
| Lilly USA, LLC | $200.44 | 2019-2022 | |
| Janssen Biotech, INC. | $139.19 | 2019-2022 | |
| Aurinia Pharma U.S., INC. | $113.40 | 2023 | |
| Pfizer INC. | $105.64 | 2019-2020 | |
| Horizon Therapeutics Plc | $89.45 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $62.69 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $55.25 | 2019-2020 | |
| Abbvie INC. | $53.26 | 2019-2020 | |
| Ucb, INC. | $52.05 | 2019-2020 | |
| Radius Health, INC. | $44.67 | 2019-2020 | |
| Celgene Corporation | $37.39 | 2019 | |
| Mallinckrodt Enterprises LLC | $34.80 | 2019 | |
| Sobi, INC | $20.04 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.92 | 2020 | |
| Merck Sharp & Dohme LLC | $13.72 | 2019 | |
| Glaxosmithkline, LLC. | $13.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.82 | 2019 | |
| Hikma Pharmaceuticals USA | $11.74 | 2019 | |
| Sebela Pharmaceuticals INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Peng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.